News & Insights.
From the Nemean Capital Team.Insights
& News
Stay informed on market opportunities, sector analysis, and transaction insights from the Nemean Capital team.
Quality of Earnings: The Diligence Process That Can Make or Break a Deal
A rigorous QoE review examines whether a company's numbers reflect sustainable economic performance — or mask risk that could affect valuation, financing, and closing certainty.
Read More →
The Reshoring Thesis: Industrial Strategy and the Shifting Geography of U.S. Manufacturing
Two years of tariff volatility and supply chain disruption have created a compelling opportunity set in U.S. mid-market manufacturing for thesis-driven capital deployment.
Read More →
The U.S. Biotech Liquidity Crisis
The U.S. biotechnology sector is facing a severe liquidity crisis, with nearly 40% of companies projected to run out of cash within a year, creating attractive opportunities for strategic investors.
Read More →Sign Up for Deals & Insights
Stay informed on market opportunities, sector analysis, and transaction insights from the Nemean Capital team.